SAGE Therapeutics Inc
NASDAQ:SAGE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SAGE Therapeutics Inc
NASDAQ:SAGE
|
US |
|
Frontier Group Holdings Inc
NASDAQ:ULCC
|
US |
|
M
|
Mercury NZ Ltd
ASX:MCY
|
NZ |
|
S
|
Sanlam Ltd
JSE:SLM
|
ZA |
|
U
|
US GoldMining Inc
NASDAQ:USGO
|
CA |
|
Finolex Industries Ltd
NSE:FINPIPE
|
IN |
|
S
|
Santam Ltd
JSE:SNT
|
ZA |
|
NU Skin Enterprises Inc
NYSE:NUS
|
US |
|
Hexatronic Group AB
F:02H0
|
SE |
|
PMV Pharmaceuticals Inc
NASDAQ:PMVP
|
US |
|
C
|
Compania Cervecerias Unidas SA
SGO:CCU
|
CL |
Shareholder Yield
Current shareholder yield for SAGE is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
SAGE Price
SAGE Therapeutics Inc
| Average Annual Return | -31.96% |
| Standard Deviation of Annual Returns | 15.15% |
| Max Drawdown | -94% |
| Market Capitalization | 543.6m USD |
| Shares Outstanding | 62 780 000 |
| Percentage of Shares Shorted | 3.94% |
